Top 10 Emergency Medicine Articles of 2016: NEJM Journal Watch Editors’ Picks
Information sourced from NEJM Journal Watch:
NEJM Journal Watch Emergency Medicine Top Stories of 2016
Richard D. Zane, MD, FAAEM
A perspective on the most important research in the field from the past year
It has been a remarkable year for practice-changing medical breakthroughs. This year has seen myriad advances and challenges, including a fundamental shift in the approach to pulmonary embolism as an outpatient disease, emergency physicians wrestling with the sudden legalization of marijuana and the impact of edible and synthetic cannabinoids, emergency medicine being placed in the center of the opioid addiction crisis, and continued change in resuscitation and sepsis guidelines. As difficult as it was to pick a top 10 list, we have done our best to highlight some of the most impactful articles published this year.
Thank you again for your continued support of NEJM Journal Watch Emergency Medicine.
Our NEJM Journal Watch Emergency Medicine Top Stories of 2016 are:
Tissue Plasminogen Activator for Severe Stroke?
Guidance for Vaccination, Diagnosis, and Treatment of Influenza in the ED
Consider Using TMP/SMX After Draining Uncomplicated Abscesses
Sharp Increase in Marijuana-Related ED Visits in Colorado by Nonresidents After Recreational Legalization
Increased Admissions for Mild Pulmonary Embolism
Can We Predict Which Children Are at Risk for Persistent Postconcussion Syndrome?
Pulmonary Embolism Response Teams: One Hospital’s Experience
High-Sensitivity Troponin Assays Can Rule Out MI in 1 Hour
Does Hyperglycemia at Discharge Predict Return Visits by Type 2 Diabetics?
Which Antiarrhythmic for Cardiac Arrest?
NEJM Journal Watch is produced by NEJM Group, a division of the Massachusetts Medical Society. Copyright ©2017 Massachusetts Medical Society. All rights reserved.
The above message comes from NEJM Journal Watch, who is solely responsible for its content.
You have received this email because you requested follow-up information to an Epocrates DocAlert® message. For more information about Epocrates, please click here.
For questions, feedback, or suggestions regarding Epocrates DocAlert® messages, please contact the Medical Information Team at email@example.com.